Inactivation of GM₁‐ganglioside β‐galactosidase by a specific inhibitor: A model for ganglioside storage disease

Keyphrases

• Gangliosides 100%
• Specific Inhibitor 100%
• β-Galactosidase (β-Gal) 100%
• Storage Diseases 100%
• Lysosomal Enzymes 66%
• Glioma 33%
• In Vitro Model 33%
• Choline Acetyltransferase (ChAT) 33%
• Lactate Dehydrogenase 33%
• Specific Activity 33%
• Neuroblastoma 33%
• Human Neurodegenerative Diseases 33%
• Hybrid Cells 33%
• Inactivator 33%
• Neuropharmacological Effect 33%
• Morphological Comparison 33%
• Suppressed Growth 33%
• Galactosylceramidase 33%
• GM1 Gangliosidosis 33%
• Cytoplasmic Bodies 33%

Biochemistry, Genetics and Molecular Biology

• Enzyme 100%
• Galactosidase 100%
• Ganglioside 100%
• Lactate Dehydrogenase 33%
• Morphology 33%
• Galactosylceramidase 33%
• Choline Acetyltransferase 33%
• GM1 Gangliosidosis 33%

Neuroscience

• Ganglioside 100%
• Galactosidase 100%
• Lysosome Enzyme 66%
• In Vitro 33%
• Neurodegenerative Disorder 33%
• Choline Acetyltransferase 33%
• Lactate Dehydrogenase 33%
• Neuroblastoma 33%
• Galactosylceramidase 33%